Trial Profile
Phase I trial of a long-acting insulin, Sulixen, in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- 15 Mar 2011 New trial record